SCHEMBL7921732

SCHEMBL7921732

CC(=O)OCC1CCSC(C)S1

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1023407 0.73
SCHEMBL4189761 0.71 ALDH1A1 (0.39) NLRP3ALDH1A1LMNAHSD17B10
SCHEMBL7933668 0.69 NLRP3 (0.36) NLRP3ALDH1A1LMNAHSD17B10
SCHEMBL13971286 0.69
SCHEMBL7921727 0.68 ALDH1A1 (0.33) NLRP3ALDH1A1LMNAHSD17B10
SCHEMBL13434034 0.64 ALDH1A1 (0.36) NLRP3ALDH1A1LMNAHSD17B10
SCHEMBL18782430 0.64 LMNA (0.39) NLRP3ALDH1A1LMNAHSD17B10
SCHEMBL24912279 0.64 ALDH1A1 (0.43) NLRP3ALDH1A1LMNAHSD17B10
SCHEMBL17550206 0.64 ALDH1A1 (0.43) NLRP3ALDH1A1LMNAHSD17B10
SCHEMBL17029138 0.64 ALDH1A1 (0.43) NLRP3ALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010031865-A1 Substituted 3-phenyluracils KLINTZ RALF (DE) 2001-10-18 US disclosed
US-6239074-B1 HERBICIDES, INSECTICIDES BASF AKTIENGESELLSCHAFT (DE) 2001-05-29 US disclosed
EP-0604491-A1 SUBSTITUTED 3-PHENYLURACILS AS HERBICIDES BASF Aktiengesellschaft (DE) 1994-07-06 EP disclosed
WO-1993006090-A1 SUBSTITUTED 3-PHENYLURACILS AS HERBICIDES BASF AKTIENGESELLSCHAFT (DE) 1993-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031865-A1 Substituted 3-phenyluracils CCR1, CCR6, CCR3 NLRP3 3892/4885ALDH1A1 1864/4885LMNA 1409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.